Home » Posts tagged with "FDA"

Ariad Requested Priority Review for Brigatinib After Achieving Breakthrough Status

Ariad Requested Priority Review for Brigatinib After Achieving Breakthrough Status

Ariad Pharmaceuticals says that they initiated an NDA or New Drug Application for its investigational candidate drug, Brigatinib which... 
Lung Cancer Experimental Trial Stopped After Former President Jimmy Carter Tumors Shrink

Lung Cancer Experimental Trial Stopped After Former President Jimmy Carter Tumors Shrink

A clinical trial for lung cancer was stopped after researchers found out that their candidate drug had statistically significant results. ... 
Zosano Enrol First Subject for Pivotal Clinical Efficacy Trial for ZP-Triptan Patch Program to Treat Migraine Attacks

Zosano Enrol First Subject for Pivotal Clinical Efficacy Trial for ZP-Triptan Patch Program to Treat Migraine Attacks

Zosano Pharma Corporation is a clinical stage pharmaceutical company that specializes in dermal delivery of therapeutic drugs. The... 
Will There Be Another Bidder for Anacor Pharmaceuticals?

Will There Be Another Bidder for Anacor Pharmaceuticals?

Is there a chance that another bidder will emerge to buy out Anacor Pharmaceuticals (ANAC) after its agreement with Pfizer? Last May... 
US Senators Initiate a Bill to Allow Generic Drugs to Come into the Market

US Senators Initiate a Bill to Allow Generic Drugs to Come into the Market

More generic drugs will be available in the market, if the Bill introduced by four US Senators will be carried out. Two Republicans... 
Why Infinity Pharmaceuticals is Failing?

Why Infinity Pharmaceuticals is Failing?

Infinity Pharmaceuticals experienced the biggest crash in the stock market last Tuesday.  The company shares fall by almost two third... 
Zafgen’s Experimental Trial Drug Shows Positive Result for Treating Type 2 Diabetes Complicated by Obesity

Zafgen’s Experimental Trial Drug Shows Positive Result for Treating Type 2 Diabetes Complicated by Obesity

Zafgen, a biopharmaceutical company reported a statistically significant result for their lead candidate drug, Beloranib, in treating... 
Will Biotech Companies Replace the Big Pharma?

Will Biotech Companies Replace the Big Pharma?

Are the Biotech companies the leading market players now? Will it take the place of Big Pharma? Big players in the biotech industry... 
Alexion Shares Drops After Clinical Trial Fails to Meet Primary Endpoint

Alexion Shares Drops After Clinical Trial Fails to Meet Primary Endpoint

Alexion Pharmaceutical shares were down to 9.7 percent last Monday, June 6, after the patients participating in the clinical trial... 
Sarepta Shares Rise after FDA Requested Additional Report on their Experimental Drug

Sarepta Shares Rise after FDA Requested Additional Report on their Experimental Drug

Sarepta Therapeutics Inc. shares rise after announcing that the US Food and Drug Authority requested for additional report on the company’s... 
J & J Combo Therapy Delay the Progression of Multiple Myeloma

J & J Combo Therapy Delay the Progression of Multiple Myeloma

Johnsons and Johnson’s announced that their clinical trial for a combination therapy can delay the progression of multiple myeloma.... 
Despite Tough Competition with Rival Drugs, Novartis Afinitor Gets Approval in Europe for Lung and Gastrointestinal Neuroendocrine Tumors

Despite Tough Competition with Rival Drugs, Novartis Afinitor Gets Approval in Europe for Lung and Gastrointestinal Neuroendocrine Tumors

Novartis blockbuster drug, Afinitor, get approval from European Regulators for the treatment of advanced lung and gastrointestinal... 
Relypsa Stock Surge after the Possibility of Buyout Rumors

Relypsa Stock Surge after the Possibility of Buyout Rumors

Relypsa, a small biotech company had a strong stock volume last Wednesday, June 1, after an analyst forecast its drug launch to be... 
Intercept’s New Approved FDA Drug to Treat Liver Disease has a Lofty Price Tag of $70,000 a year!

Intercept’s New Approved FDA Drug to Treat Liver Disease has a Lofty Price Tag of $70,000 a year!

For almost two decades, patients suffering from Primary Biliary Cholangitis have only one treatment option. This proves to be a problem... 
Flexion Shares Soar 50% Higher When FDA Endorsed their Lead Drug

Flexion Shares Soar 50% Higher When FDA Endorsed their Lead Drug

Flexion Therapeutics shares went 50% higher when they got a word from FDA that their clinical data results were acceptable for NDA... 
Jazz Pharmaceutical is Buying Celator for $1.5 Billion

Jazz Pharmaceutical is Buying Celator for $1.5 Billion

Jazz is acquiring Celator Pharmaceuticals for a price double its market value of $740 million.  Celator is a biopharmaceutical company... 
Intercept’s Ocaliva got Accelerated FDA Approval for the Treatment of PBC

Intercept’s Ocaliva got Accelerated FDA Approval for the Treatment of PBC

Intercept, a biopharmaceutical company got FDA approval for Ocaliva (Obeticholic Acid), a drug used for treating Primary Biliary Cholangitis. The... 
Biogen and AbbVie Wins FDA Approval for an Injectable Drug Used to Treat MS in US

Biogen and AbbVie Wins FDA Approval for an Injectable Drug Used to Treat MS in US

Biogen and AbbVie announced that it finally got the approval of the Food and Drug Administration to market Zinbryta or daclizumab,... 
Braeburn Pharmaceutical’s Probuphine Got FDA Approval as Treatment for Opioid Dependence

Braeburn Pharmaceutical’s Probuphine Got FDA Approval as Treatment for Opioid Dependence

It is a call for celebration for Braeburn Pharmaceutical as their Probuphine Implant finally got its FDA approval. This is the first... 
Samsung Invests on Biosimilar Drugs to Expand their US Market

Samsung Invests on Biosimilar Drugs to Expand their US Market

Samsung Group, a well known South Korean company that provides semiconductors, televisions and smartphones is now expanding their business... 
FDA’s Delayed Decision to Sarepta’s Eteplirsen: Favorable or not?

FDA’s Delayed Decision to Sarepta’s Eteplirsen: Favorable or not?

Thursday, May 26, was the deadline for the Food and Drug Authority to approve Sarepta Drug- Eteplirsen as potential treatment for Duchenne...